Gino Cédric AGBOTA

Dr. Gino Cédric AGBOTA

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
GAGino Cédric AGBOTA
Gino Cédric AGBOTA
MBMaryline Bonnet
Maryline Bonnet
CLChristian Lienhardt
Christian Lienhardt
Tuberculosis infection (TBI) is defined as a state of infection in which individuals host live Mycobacterium tuberculosis with or without clinical signs of active TB. It is now understood as a dynamic process covering a spectrum of responses to infection resulting from the interaction between the TB bacilli and the host immune system. The global burden of TBI is about one-quarter of the world’s population, representing a reservoir of approximately 2 billion people. On average, 5–10% of people who are infected will develop TB disease over the course of their lives, but this risk is enhanced in a series of conditions, such as co-infection with HIV. The End-TB strategy promotes the programmatic management of TBI as a crucial endeavor to achieving global targets to end the TB epidemic. The current development of new diagnostic tests capable of discriminating between simple TBI and active TB, combined with novel short-course preventive treatments, will help achieve this goal. In this paper, we present the current situation and recent developments of management of TBI and the operational challenges.

19 September 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GAGino Cédric AGBOTA
Gino Cédric AGBOTA
KPKatja Polman
Katja Polman
FWFrank Wieringa
Frank Wieringa
KNKimberly Nehal
Kimberly Nehal
MAManfred Accrombessi
Manfred Accrombessi
VBValérie Briand
Valérie Briand
Malaria and schistosomiasis represent two of the most prevalent and disabling parasitic infections in developing countries. Few studies have evaluated the effect of maternal schistosomiasis and malaria in the peri-conceptional period on infant’s risk of infection. In Benin, women were followed from the preconception period until delivery. Subsequently, their children were followed from birth to 3 months of age. Pre-pregnancy malaria, malaria in pregnancy (MiP)—determined monthly using a thick blood smear—and urinary schistosomiasis—determined once before pregnancy and once at delivery using urine filtration—were the main maternal exposures. Infant’s febrile infection (fever with respiratory, gastrointestinal and/or cutaneous clinical signs anytime during follow-up) was the main outcome. In a secondary analysis, we checked the relation of malaria and schistosomiasis with infant’s hemoglobin (Hb) concentration. Both effects were separately assessed using logistic/mixed linear regression models. The prevalence of MiP was 35.7% with 10.8% occurring during the 1st trimester, and the prevalence of schistosomiasis was 21.8%. From birth to 3 months, 25.3% of infants had at least one episode of febrile infection. In multivariate analysis, MiP, particularly malaria in the 1st trimester, was significantly associated with a higher risk of infant’s febrile infection (aOR = 4.99 [1.1; 22.6], p = 0.03). In secondary results, pre-pregnancy malaria and schistosomiasis were significantly associated with a lower infant’s Hb concentration during the first 3 months. We evidenced the deleterious effect of maternal parasitic infections on infant’s health. Our results argue in favor of the implementation of preventive strategies as early as in the peri-conception.

1 November 2021 in Environmental Research
Verified
Journal Article
Closed access
SDSarah Davies
Sarah Davies
VBValerie Briand
Valerie Briand
MAManfred Accrombessi
Manfred Accrombessi
NFNadine Fievet
Nadine Fievet
BBBarbara Le Bot
Barbara Le Bot
FBFlorence Bodeau-Livinec
Florence Bodeau-Livinec

29 August 2019 in Pediatric Obesity
Verified
Journal Article
Closed access
PDF file
GAGino Cédric AGBOTA
Gino Cédric AGBOTA
NFNadine Fievet
Nadine Fievet
BHBarbara Heude
Barbara Heude
MAManfred Accrombessi
Manfred Accrombessi
UAUrbain Ahouayito
Urbain Ahouayito
VBValérie Briand
Valérie Briand

7 December 2018 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
GAGino Cédric AGBOTA
Gino Cédric AGBOTA
MAManfred Accrombessi
Manfred Accrombessi
GCGilles Cottrell
Gilles Cottrell
YMYves Martin-Prével
Yves Martin-Prével
JMJacqueline Milet
Jacqueline Milet
VBValérie Briand
Valérie Briand
Background. According to the Developmental Origins of Health and Diseases paradigm, the fetal period is highly vulnerable and may have profound effects on later health. Few studies assessed the effect of small-for-gestational age (SGA), a proxy for fetal growth impairment, on risk of malaria during infancy in Africa. Methods. We used data from a cohort of 398 mother-child pairs, followed from early pregnancy to age 1 year in Benin. Malaria was actively and passively screened using thick blood smear. We assessed the effect of SGA on risk of malaria infection and clinical malaria from birth to 12 months, after stratifying on the infant's age using a logistic mixed regression model. Results. After adjustment for potential confounding factors and infant's exposure to mosquitoes, SGA was associated with a 2-times higher risk of malaria infection (adjusted odds ratio [aOR] = 2.16; 95% confidence interval [CI], 1.04-4.51; P = .039) and clinical malaria (aOR = 2.33; 95% CI, 1.09-4.98; P = .030) after age 6 months. Conclusion. Results suggest higher risk of malaria during the second semester of life in SGA infants, and argue for better follow-up of these infants after birth, as currently for preterm babies.

29 May 2025 in Microbial Genomics
Verified
Journal Article
Open access
BFBalotin Fogang
Balotin Fogang
EGEmilie Guillochon
Emilie Guillochon
CKClaire Kamaliddin
Claire Kamaliddin
GAGino Cédric AGBOTA
Gino Cédric AGBOTA
SESem Ezinmegnon
Sem Ezinmegnon
ACAntoine Claessens
Antoine Claessens
Background. In Africa, the clearance time for Plasmodium falciparum severe malaria varies significantly, likely due to the complexity of P. falciparum infections and the sequestration phenomenon exhibited by this parasite. This study aims to evaluate different methods to study the intra-host dynamics of polyclonal infections during parasite clearance under antimalarial treatment. Additionally, it seeks to determine the association between parasite clearance rate following artesunate or quinine treatment and the genetic complexity of P. falciparum in Beninese children with severe malaria. Methods. Sixty-five P. falciparum severe malaria individuals diagnosed by microscopy and treated with artesunate or quinine were sampled every 8 h for 24 h. Using whole-genome sequencing (WGS) data, we estimated the multiplicity of infection (MOI) with three algorithms ( Fws , THE REAL McCOIL and RoH). We then characterized the P. falciparum genetic complexity in WGS-identified polyclonal infections using amplicon sequencing (AmpSeq) on DNA extracted from plasma and the red blood cell pellet. Results. AmpSeq demonstrated greater sensitivity in detecting multiple genomes within isolates compared to WGS methods. The MOI from AmpSeq was significantly higher in red blood cell pellets compared to plasma (2.4 vs. 1.8 distinct microhaplotypes per isolate). However, at parasitaemia over 1,000 parasites per microlitre, the same MOI was detected in both plasma and pellet samples in 85.4% of the isolates. We observed a high variability in parasite clearance rate among participants, but it was not associated with parasite MOI at diagnosis. Interestingly, in 60.9% of participants, previously undetected microhaplotypes appeared in circulation 16 h after treatment initiation. Conclusion. These findings demonstrate that combining different haplotyping techniques effectively determines parasite genetic complexity. Additionally, plasma can be effectively used for parasite genotyping at sufficient parasitaemia levels. The parasite clearance rate of severe malaria is independent of parasite MOI. However, genotyping a single blood sample upon hospital admission does not capture the full spectrum of parasite genotypes present in the infection.